Sacubitril, also known as AHU377, is angiotensin receptor neprilysin inhibitor being studied for use in combination with valsartan for heart failure. Sacubitril is a prodrug that is activated to LBQ657 by de-ethylation via esterases. LBQ657 inhibits the enzyme neprilysin, which is responsible for the degradation of atrial and brain natriuretic peptide, two blood pressure lowering peptides that work mainly by reducing blood volume.
For research use only. We do not sell to patients.
Chemical Information
Name
Sacubitril sodium
Iupac Chemical Name
Sacubitril sodium
Synonyms
Sacubitril sodium; AHU377; AHU 377; AHU-377; LCZ696